FDA OKs First 'Digital Pill' That Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Abilify | Bipolar | Depression | Food and Drug Administration (FDA) | Health | Mania | Schizophrenia